Skip to content
stoqly
en · USD

Appearance

Language

Currency

Popular

All currencies

Data is in US dollars, converted at the exchange rate of Oct 28, 2026.

Sign in

Chad M Robins

CEO and Chairman, Director, Adaptive Biotechnologies Corp

Bought, 12 months
$0.0M
Sold, 12 months
$39.8M
Companies
1
Latest trade
Aug 18, 2026

Companies

Adaptive Biotechnologies CorpCEO and Chairman, Director −$39.8M

Trades

ADPT Sold 278,676 shares at $24.48 $6.8M Aug 18 Form 4
ADPT Sold 321,324 shares at $25.08 $8.1M Aug 17 Form 4
ADPT Sold 37,263 shares at $15.19 · planned $0.6M Apr 8 Form 4
ADPT Sold 83,332 shares at $14.41 · planned $1.2M Apr 6 Form 4
ADPT Sold 470,167 shares at $13.17 $6.2M Mar 11 Form 4
ADPT Sold 53,083 shares at $15.52 · planned $0.8M Mar 3 Form 4
ADPT Sold 289,024 shares at $15.82 · planned $4.6M Mar 2 Form 4
ADPT Sold 182,891 shares at $15.99 · planned $2.9M Feb 27 Form 4
ADPT Sold 124,998 shares at $18.44 · planned $2.3M Feb 2 Form 4
ADPT Sold 124,998 shares at $15.59 · planned $1.9M Jan 5 Form 4
ADPT Sold 124,998 shares at $18.94 · planned $2.4M Dec 1 Form 4
ADPT Sold 35,736 shares at $19.68 · planned $0.7M Nov 26 Form 4
ADPT Sold 1,867 shares at $15.00 · planned $0.0M Nov 12 Form 4
ADPT Sold 1,237 shares at $14.57 · planned $0.0M Nov 11 Form 4
ADPT Sold 86,161 shares at $14.73 · planned $1.3M Nov 10 Form 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

↑ ↓ to move · ↵ to open